Robert Horsburgh
Profiles

Charles R Horsburgh, Jr, MD

Professor, Global Health - Boston University School of Public Health

(617) 358-3758
rhorsbu@bu.edu
Crosstown Center
View Full Profile at BUMC

Biography

Dr. Horsburgh has 30 years of experience in public health and medicine. He currently holds faculty positions in the Departments of Epidemiology, Biostatistics, Global Health and Medicine. Dr. Horsburgh teaches courses in the Epidemiology of AIDS, the Epidemiology of Tuberculosis and Vaccine Epidemiology. His research focuses on tuberculosis, nontuberculous mycobacterial infections and opportunistic infections in AIDS. Currently, he is involved in research in Brazil, India, South Africa, Tanzania, Vietnam and the Philippines. He is a member of the Board of Directors of the International Union Against Tuberculosis and Lung Disease (IUATLD) and Chairman of the Steering Committee of RESIST-TB, an international organization dedicated to improving MDR-TB treatment through Clinical Trials and dissemination of best practices (www.resisttb.org).

Other Positions

  • Professor, Epidemiology - Boston University School of Public Health
  • Professor, Biostatistics - Boston University School of Public Health
  • Professor, Medicine - Boston University Chobanian & Avedisian School of Medicine

Education

  • Case Western Reserve University, MD Field of Study: Medicine
  • Yale University, MS Field of Study: Urban Studies
  • Princeton University, AB Field of Study: Architecture

Websites

Classes Taught

  • SPHEP730
  • SPHEP764
  • SPHEP784
  • SPHEP911
  • SPHGH941

Publications

  • Published on 8/1/2026

    Lokhande RV, Arora PR, Bhagure GR, Joubert A, Udwadia ZF, Rodrigues C, Gupta A, Mave V, Raichur P, Gaikwad S, Khan R, Pradeep A, Wiesner L, Tornheim JA, Horsburgh CR, Ashavaid TF. Analytical Method Development and Validation for Clofazimine in Human Plasma and Application of LC-MS/MS Based Methods for Clofazimine and Bedaquiline in Indian MDR-TB Patients Stratified by HIV Coinfection. J Mass Spectrom. 2026 Aug; 61(8):e70093. PMID: 42528125.

     Read At: PubMed
  • Published on 8/1/2026

    Deleger JN, Khatami SN, Jones M, Jalali MS, Paltiel AD, Wong EB, Florance G, Freedberg KA, Wood R, Horsburgh CR, Reddy KP. Cost-effectiveness of community tuberculosis screening in South Africa. Am J Respir Crit Care Med. 2026 Aug 01; 212(8):1793-1805. PMID: 42085271.

     Read At: PubMed
  • Published on 7/23/2026

    Campbell JI, Brooks MB, Dankovchik J, Giebultowicz S, Falkenstein A, Angier H, Horsburgh CR, Tschampl CA, Haberer JE, Bressler J, Epstein RL, Jenkins HE, Jacobson KR. Uncovering Household Tuberculosis Infection Testing and Care Patterns Using a Novel Bioinformatics Linkage Strategy. Clin Infect Dis. 2026 Jul 23; 83(1):e167-e176. PMID: 41668263.

     Read At: PubMed
  • Published on 6/15/2026

    Horsburgh CR, Jenkins HE, Kendall EA, Esmail H, Chiang CY, White LF, Marks GB. Scoping review of community-wide screening to break the chain of TB transmission. IJTLD Open. 2026 Jun; 3(6):356-363. PMID: 42305733.

     Read At: PubMed
  • Published on 6/5/2026

    Chen C, Hu X, Horsburgh CR, Wu W, Chen C, Shao Y, Jiang H, Xu Z, Jiang J, Liu Q, Lu W, Zhu L, Martinez L. Mycobacterium tuberculosis transmission from tuberculosis patients with and without recognized symptoms: a case-contact study in eastern China. Nat Commun. 2026 Jun 05. PMID: 42248852.

     Read At: PubMed
  • Published on 5/20/2026

    Wijk M, Denti P, Gausi K, Myers B, Carney T, White LF, Theron D, Parry CDH, Horsburgh CR, Rawoot N, Warren RM, Court R, Kulkarni SG, Farhat MR, Buys C, Malatesta S, Weber SE, Kulkarni S, McIlleron H, Jacobson KR, Kloprogge F. Insights into the Role of Rifampicin Exposure and Clinical Baseline Covariates on the Response to Pulmonary Tuberculosis Treatment. Clin Infect Dis. 2026 May 20; 82(5):e1014-e1022. PMID: 41133922.

     Read At: PubMed
  • Published on 5/15/2026

    Campbell JI, Vachharajani O, Dubois MM, Martinez L, Christos PJ, Herlihy JM, Jenkins HE, Horsburgh CR, Jacobson KR, Powis KM. Tuberculosis in children who are HIV-exposed uninfected: A systematic review and metaanalysis. AIDS. 2026 May 15. PMID: 42138367.

     Read At: PubMed
  • Published on 5/14/2026

    Brown TS, Nelson K, Kissler S, Martinez L, Horsburgh CR, White LF, Mathema B, Jacobson KR. Understanding and exploiting superspreading to disrupt Mycobacterium tuberculosis transmission. Lancet Infect Dis. 2026 May 14. PMID: 42134384.

     Read At: PubMed
  • Published on 5/4/2026

    Gallini J, Singh UB, Dauphinais M, Sarkar S, Carwile M, Kumar R, Rao R, Chaudhary A, McQuaid CF, Maloomian K, Sinha S, Mehta S, Dowdy DW, Liu AF, Linas BP, Horsburgh CR, White LF, Sinha P. Cost-effectiveness of in-kind nutritional support for impoverished persons with tuberculosis to reduce mortality and disengagement from care in India: a modelling study. BMJ Glob Health. 2026 May 04; 11(5). PMID: 42082204.

     Read At: PubMed
  • Published on 5/1/2026

    Zheng A, Pletner E, Middelkoop K, Neilan AM, Horsburgh CR, Paltiel AD, Freedberg KA, Wood R, Reddy KP. Potential long-acting tuberculosis treatment for people with HIV: cost-effectiveness benchmarks. Ann Am Thorac Soc. 2026 May 01; 23(5):745-753. PMID: 41721756.

     Read At: PubMed

View 389 more publications:View Full Profile at BUMC

News & In the Media

View all profiles